Alnes Pharma India Private Limited, a active private limited company, was established on 24 February 2021 in Bangalore North, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33100KA2021PTC144543. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 35 professional, Its leadership includes Negalaguli Aravinda (Director), Ademane Prabhavati (Director), Suresha Eranna (Director). It holds ₹5.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No 803 3Rd Floor B Sector Mig Khb Colony, 100 Ft Mother Dairy Road, Bangalore North, Karnataka, 560064.
U33100KA2021PTC144543
144543
24 February 2021
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Alnes Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Negalaguli Aravinda | Director | 24 Feb 2021 | Current |
| Ademane Prabhavati | Director | 24 Feb 2021 | Current |
| Suresha Eranna | Director | 24 Feb 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alnes Pharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 156.51% increase. The company also saw a substantial improvement in profitability, with a 146.73% increase in profit. The company's net worth Soared by an impressive increase of 49.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Alnes Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2024 | Others | ₹4.50 M | Open |
| 12 May 2022 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Alnes Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Alnes Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alnes Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alnes Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Others amounted to Rs. 4.50 M with Charge ID 100969681 was registered on 05 Aug 2024. was recorded as a recent event.
Progress on Alnes Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on A charge with Others amounted to Rs. 1.00 M with Charge ID 100577904 was registered on 12 May 2022. was documented.
Progress on Negalaguli Aravinda was appointed as a Director was appointed as a Director on 24 Feb 2021 & has been associated with this company since 4 years 9 months . was documented.
The activity Ademane Prabhavati was appointed as a Director was appointed as a Director on 24 Feb 2021 & has been associated with this company since 4 years 9 months . was completed.
The CIN of Alnes Pharma India Private Limited is U33100KA2021PTC144543.
Alnes Pharma India Private Limited is headquartered at No 803 3Rd Floor B Sector Mig Khb Colony, 100 Ft Mother Dairy Road, Bangalore North, Karnataka, 560064.
Alnes Pharma India Private Limited was incorporated on 24 February 2021.
The current directors of Alnes Pharma India Private Limited are
The primary industry of Alnes Pharma India Private Limited is Trade.
Alnes Pharma India Private Limited is unlisted.
The authorized capital of Alnes Pharma India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Alnes Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX